BREAKFAST PROGRAM | 7:00 am – 8:00 am

7:00 am – 8:00 am
Don’t miss this opportunity to engage faculty and colleagues in a smaller group setting. Speakers will deliver didactic presentations on a hot topic and then take questions from the audience. Breakfast will be provided.

GENERAL SESSIONS | 8:00 am – 11:45 am

Pediatrics, Pediatric Surgery, Gene Therapy and Upcoming Technologies

Session Chairs: R.V. Paul Chan, MD, MSc, FACS; Darius M. Moshfeghi, MD; Hiroko Terasaki, MD, PhD
8:00 am – 8:07 am
New Therapy Approaches for Retinopathy of Prematurity
Darius M. Moshfeghi, MD
8:07 am – 8:14 am
Artificial Intelligence for ROP Screening
R.V. Paul Chan, MD, MSc, FACS
8:14 am – 8:21 am
Subretinal Chip Implant for Retinal Degeneration
Helmut Sachs, MD
8:21 am – 8:28 am
What is the Correct Anti-VEGF Dose for ROP?
Maria A. Martinez-Castellanos, MD
8:28 am – 8:35 am
Surgical Management of Sticklers Syndrome
Antonio Ciardella, MD
8:35 am – 8:42 am
PHPV
Hiroko Terasaki, MD, PhD
8:42 am – 8:49 am
Current Management of Pediatric RRD
G. Baker Hubbard, MD
8:49 am – 8:56 am
Gene Therapy for RPE65 Mutated Retinal Degenerations
Audina M. Berrocal, MD
8:56 am – 9:03 am
The Surgical Management of Familial Exudative Vitreoretinopathy
Sengul Ozdek, MD
9:03 am – 9:25 am
Panel Discussion: Surgical ROP/Pediatric Case Analysis
Moderator: R.V. Paul Chan, MD, MSc, FACS
Panelists: Antonio Ciardella, MD; Hiroko Terasaki, MD; Maria A. Martinez-Casteallanos, MD; Sengul Ozdek, MD; Darius M. Moshfeghi, MD

Uveitis

Session Chairs: Sofia N. Androudi, MD, PhD; Steven Yeh, MD
9:30 am – 9:37 am
Diagnostic Vitrectomy for Uveitis
Steven Yeh, MD
9:37 am – 9:44 am
Using OCTA to Monitor Uveitis
Sumit Sharma, MD
9:44 am – 9:51 am
New Approaches to the Treatment of Uveitic Macular Edema
Pauline T. Merrill, MD
9:51 am – 9:58 am
MUST Study Outcomes and Impact on Clinical Practice
Thomas A. Albini, MD
9:58 am – 10:05 am
Systemic Therapies for Uveitis
10:05 am – 10:12 am
Future Therapies for Uveitis
10:12 am – 10:19 am
Abstract Presentation
10:19 am – 10:40 am
Panel Discussion
Moderator: Sofia N. Androudi, MD, PhD
Panelists: Thomas Albini, MD; Pauline T. Merrill, MD; Sumit Sharma, MD; Steven Yeh, MD

First-time Presentations of Clinical Trials and Late Breakers

Session Chairs: Pravin U. Dugel, MD; Sundaram Natarajan, MD
10:45 am – 10:52 am
Optimizing DME Treatment with Decreased Injection Frequency with Long-term Steroid Implants
Daniel Roth, MD
10:52 am – 10:59 am
One Year Results of a Randomized, Double-masked, Sham-controlled Phase 4 Study of the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept with Adjunctive Photodynamic Therapy in Patients with Polypoidal Choroidal Vasculopathy (ATLANTIC STUDY)
Prof. Rufino Silva, MD, PhD, FEBO
10:59 am – 11:06 am
Technology and Artificial Intelligence in the Retina Landscape
Linda A. Lam, MD, MBA
11:06 am – 11:13 am
The Evidence Behind Extended Anti-VEGF Dosing in Neovascular Age-related Macular Degeneration: A 5 Trial Cross Comparison
Theodore Leng, MD, FACS
11:13 am – 11:44 am
Case To Be Announced
Speaker To Be Announced
11:45 am
Closing Remarks and Adjournment